These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33053607)

  • 1. Role of eIF4A1 in triple-negative breast cancer stem-like cell-mediated drug resistance.
    Raman D; Tiwari AK
    Cancer Rep (Hoboken); 2022 Dec; 5(12):e1299. PubMed ID: 33053607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.
    Modelska A; Turro E; Russell R; Beaton J; Sbarrato T; Spriggs K; Miller J; Gräf S; Provenzano E; Blows F; Pharoah P; Caldas C; Le Quesne J
    Cell Death Dis; 2015 Jan; 6(1):e1603. PubMed ID: 25611378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eIF4A1-dependent mRNAs employ purine-rich 5'UTR sequences to activate localised eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation.
    Schmidt T; Dabrowska A; Waldron JA; Hodge K; Koulouras G; Gabrielsen M; Munro J; Tack DC; Harris G; McGhee E; Scott D; Carlin LM; Huang D; Le Quesne J; Zanivan S; Wilczynska A; Bushell M
    Nucleic Acids Res; 2023 Feb; 51(4):1859-1879. PubMed ID: 36727461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells.
    Howard CM; Estrada M; Terrero D; Tiwari AK; Raman D
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process.
    Xia T; Dai XY; Sang MY; Zhang X; Xu F; Wu J; Shi L; Wei JF; Ding Q
    Adv Sci (Weinh); 2024 Jan; 11(1):e2305142. PubMed ID: 37983610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer.
    Wang C; Leavenworth J; Zhang C; Liu Z; Yuan KY; Wang Y; Zhang G; Wang S; Cui X; Zhang Y; Bae S; Zhou J; Wang L; Liu R
    Oncogene; 2022 May; 41(19):2778-2785. PubMed ID: 35361883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness.
    Sridharan S; Robeson M; Bastihalli-Tukaramrao D; Howard CM; Subramaniyan B; Tilley AMC; Tiwari AK; Raman D
    Front Oncol; 2019; 9():1311. PubMed ID: 31867270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.
    Qayoom H; Wani NA; Alshehri B; Mir MA
    Future Oncol; 2021 Nov; 17(31):4185-4206. PubMed ID: 34342489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
    Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All trans-retinoic acid (ATRA) elevated eukaryotic translation initiation factor 4A1 (eIF4A1) mRNA in ATRA-responsive vitiliginous epidermis.
    Lee AY; Kim NH; Park SW
    Pigment Cell Res; 2004 Dec; 17(6):659-67. PubMed ID: 15541024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with
    Peters TL; Tillotson J; Yeomans AM; Wilmore S; Lemm E; Jiménez-Romero C; Amador LA; Li L; Amin AD; Pongtornpipat P; Zerio CJ; Ambrose AJ; Paine-Murrieta G; Greninger P; Vega F; Benes CH; Packham G; Rodríguez AD; Chapman E; Schatz JH
    Clin Cancer Res; 2018 Sep; 24(17):4256-4270. PubMed ID: 29844128
    [No Abstract]   [Full Text] [Related]  

  • 12. Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer.
    Nedeljković M; Tanić N; Prvanović M; Milovanović Z; Tanić N
    Breast Cancer; 2021 May; 28(3):727-736. PubMed ID: 33420675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer.
    Cencic R; Im YK; Naineni SK; Moustafa-Kamal M; Jovanovic P; Sabourin V; Annis MG; Robert F; Schmeing TM; Koromilas A; Paquet M; Teodoro JG; Huang S; Siegel PM; Topisirovic I; Ursini-Siegel J; Pelletier J
    Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2318093121. PubMed ID: 38232291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer.
    Nath A; Mitra S; Mistry T; Pal R; Nasare VD
    Med Oncol; 2021 Nov; 39(1):14. PubMed ID: 34812991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer.
    Huang WC; Chi HC; Tung SL; Chen PM; Shih YC; Huang YC; Chu PY
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the thermal response of rice eukaryotic transcription factor
    Singha DL; Maharana J; Panda D; Dehury B; Modi MK; Singh S
    J Biomol Struct Dyn; 2021 Apr; 39(7):2575-2584. PubMed ID: 32367760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
    Xia M; Zu X; Chen Z; Wen G; Zhong J
    Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5' leader regions.
    Steinberger J; Shen L; J Kiniry S; Naineni SK; Cencic R; Amiri M; Aboushawareb SAE; Chu J; Maïga RI; Yachnin BJ; Robert F; Sonenberg N; Baranov PV; Pelletier J
    Nucleic Acids Res; 2020 Sep; 48(17):9521-9537. PubMed ID: 32766783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.